PHT Corporation v. eTrials Worldwide

PHT Corporation sued eTrials Worldwide for patent infringement of PHT's patent for of electronic patient reported outcome (ePRO) solutions software. PHT Corporation, the market-leading provider of electronic patient reported outcome (ePRO) solutions used in over 165 trials worldwide, today announced that it has reached an agreement with etrials Worldwide, Inc to settle the intellectual property lawsuit filed by PHT in July, 2004. PHT Corporation is the market-leading provider of electronic patient reported outcome (ePRO) solutions used in over 165 trials worldwide. More than 65 biopharmaceutical and medical device companies, including 13 of the top 15 drug development firms in the world, rely on PHT's innovative and comprehensive ePRO solutions for their Phase I-IV clinical studies. PHT's integrated Product Suite enables successful clinical trials by improving data quality, reducing data variance, and providing real-time access to the data collected. FDA and other regulatory authorities have approved new drug applications that include endpoint data collected using PHT's Product Suite. PHT's experience includes more than 75,000 subjects at 9,000 clinical sites in 61 languages and 59 countries around the globe. PHT is headquartered in Charlestown, MA, and Geneva, Switzerland.

The defenses asserted by etrials Worldwide, Inc. are not available.